NASH May Up Risk of Heart Failure

NASH May Up Risk of Heart Failure

by Scott Harris, Contributing Writer, MedPage Today July 27, 2017 This article is a collaboration between MedPage Today® and: Medpage Today “Despite … limitations, our study provides evidence that the pathogenesis of subclinical heart failure may relate to...
Pipeline Review for NASH Drugs, July 2017

Pipeline Review for NASH Drugs, July 2017

Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Non-Alcoholic Steatohepatitis (NASH) – Pipeline Review, H2 2018, provides an overview of the Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline landscape....
NASH Now Affecting 16 Million Americans

NASH Now Affecting 16 Million Americans

Lydia Ramsey July 6, 2017 Millions of people are living with a “silent” disease they’ve likely never heard of. NASH, short for nonalcoholic steatohepatitis, is a type of liver disease in which liver fat builds up in people. NASH has become more...